Rivastigmine
- Product NDC
- 65162-826
- 11-digit product format
- 651620826
- Labeler code
- 65162
- Product ID
- 65162-826_cf03b1e8-cd2f-44ee-afab-2de64b435b45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA207308
- Marketing category
- ANDA
- Marketing start
- 2015-06-30
- Substance
- RIVASTIGMINE
- Active strength
- 9.5 mg/24h
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rivastigmine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIVASTIGMINE | 9.5 mg/24h |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | PKI06M3IW0 |
| Rxcui | 725021, 725023, 1308569 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65162-826-34 | Rivastigmine | 30 in 1 CARTON | PATCH | 30 | | 17 |
| 65162-826-34 | Rivastigmine | 24 h in 1 PATCH | PATCH | 24 | | 17 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-826 | RIVASTIGMINE PATCH [AMNEAL PHARMACEUTICALS LLC] | 17 | Current NDC, Legacy NDC, 2 package rows | 20250323_8b671fc9-8cb0-4406-a9ee-7c95086d6200.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-826-34 | 65162082634 | 30 PATCH in 1 CARTON (65162-826-34) / 24 h in 1 PATCH | 30 patch | 2015-06-30 | 0000-00-00 | No | No | Current |